– Latest Data from the PURPOSE Program Further Demonstrates the Safety and Efficacy Profile of Twice-Yearly Lenacapavir for HIV Prevention – “Striving for continuous progress in HIV means delivering ...

I fear a new HIV and Aids epidemic is coming – and the world won’t care, UN official warns - At a screening for The ...

A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...

Systematic synthesis encompassed 43 studies (21 in vitro, 14 in vivo, 8 clinical), highlighting a limited clinical evidence base and substantial methodological heterogeneity across constructs, targets ...

A new HIV treatment could end the need for a daily pill and allow people to go drug free for up to two years. But antiviral medicine, for the 113,500 people living with HIV, costs the UK more than ...

As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention, RFI spoke with infectious disease specialist Ndong Essomba Bitchoka about ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Example antibody-drug conjugate A recent experimental treatment may offer a new method to ...

A pioneering new public health campaign is launching to shatter decades of silence and outdated myths by highlighting a ...

The U.S. Food and Drug Administration (FDA) approved a new combination pill to treat HIV-1 infection in adults, according to an agency press release. The new pill, called Stribild, contains two new ...

UNAIDS report warns funding pressures threaten HIV gains, while highlighting support from India and China as the world remains off track to end AIDS by 2030 ...

A new public health campaign from a local charity is urging people to be aware of developments in HIV medicine.  It’s been ...